<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Acute respiratory distress syndrome,Respiratory pathology,Respiratory pathology,1988,Acute renal failure,Adenoid hypertrophy,Airway,Antibiotic,Arterial blood gas,Asthma,Atelectasis" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Acute respiratory distress syndrome - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Acute respiratory distress syndrome</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    	    <!-- start content -->
	    <table class="infobox" style="width: 200px; font-size: 95%; text-align: left;">
<caption style="background: lightgrey; font-size: 95%;"><b>Acute respiratory distress syndrome</b><br />
<i>Classification &amp; external resources</i></caption>
<tr>
<th><a href="../../../i/c/d/ICD_10d0.html" title="ICD">ICD</a>-<a href="../../../l/i/s/List_of_ICD-10_codes_1183.html" title="List of ICD-10 codes">10</a></th>
<td><a href="../../../i/c/d/ICD-10_Chapter_J_9d9b.html" title="ICD-10 Chapter J">J</a><a href="http://www.who.int/classifications/apps/icd/icd10online/?gj80.htm+j80" class="external text" title="http://www.who.int/classifications/apps/icd/icd10online/?gj80.htm+j80" rel="nofollow">80.</a></td>
</tr>
<tr>
<th><a href="../../../i/c/d/ICD_10d0.html" title="ICD">ICD</a>-<a href="../../../l/i/s/List_of_ICD-9_codes_cdaa.html" title="List of ICD-9 codes">9</a></th>
<td><a href="http://www.icd9data.com/getICD9Code.ashx?icd9=518.5" class="external text" title="http://www.icd9data.com/getICD9Code.ashx?icd9=518.5" rel="nofollow">518.5</a>, <a href="http://www.icd9data.com/getICD9Code.ashx?icd9=518.82" class="external text" title="http://www.icd9data.com/getICD9Code.ashx?icd9=518.82" rel="nofollow">518.82</a></td>
</tr>
<tr>
<th><a href="../../../d/i/s/Diseases_Database_9859.html" title="Diseases Database">DiseasesDB</a></th>
<td><a href="http://www.diseasesdatabase.com/ddb892.htm" class="external text" title="http://www.diseasesdatabase.com/ddb892.htm" rel="nofollow">892</a></td>
</tr>
<tr>
<th><a href="../../../m/e/d/MedlinePlus_0b70.html" title="MedlinePlus">MedlinePlus</a></th>
<td><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000103.htm" class="external text" title="http://www.nlm.nih.gov/medlineplus/ency/article/000103.htm" rel="nofollow">000103</a></td>
</tr>
<tr>
<th><a href="../../../e/m/e/EMedicine_a89c.html" title="EMedicine">eMedicine</a></th>
<td><a href="http://www.emedicine.com/med/topic70.htm" class="external text" title="http://www.emedicine.com/med/topic70.htm" rel="nofollow">med/70</a>&#160;</td>
</tr>
</table>
<p><b>Acute respiratory distress syndrome</b> (<b>ARDS</b>), also known as <b>respiratory distress syndrome</b> (<b>RDS</b>) or <b>adult respiratory distress syndrome</b> (in contrast with <a href="../../../i/n/f/Infant_respiratory_distress_syndrome.html" title="Infant respiratory distress syndrome">IRDS</a>) is a serious reaction to various forms of injuries to the <a href="../../../l/u/n/Lung.html" title="Lung">lung</a>. This is the most important disorder resulting in increased permeability <a href="../../../p/u/l/Pulmonary_edema.html" title="Pulmonary edema">pulmonary edema</a>.</p>
<p>ARDS is a severe <a href="../../../l/u/n/Lung.html" title="Lung">lung</a> disease caused by a variety of direct and indirect insults. It is characterized by <a href="../../../i/n/f/Inflammation.html" title="Inflammation">inflammation</a> of the lung <a href="../../../p/a/r/Parenchyma.html" title="Parenchyma">parenchyma</a> leading to impaired <a href="../../../g/a/s/Gas_exchange.html" title="Gas exchange">gas exchange</a> with concomitant systemic release of inflammatory mediators causing <a href="../../../i/n/f/Inflammation.html" title="Inflammation">inflammation</a>, <a href="../../../h/y/p/Hypoxia_%28medical%29.html" title="Hypoxia (medical)">hypoxemia</a> and frequently resulting in <a href="../../../m/u/l/Multiple_organ_failure.html" title="Multiple organ failure">multiple organ failure</a>. This condition is life threatening and often lethal, usually requiring <a href="../../../m/e/c/Mechanical_ventilation.html" title="Mechanical ventilation">mechanical ventilation</a> and admission to an <a href="../../../i/n/t/Intensive_care_unit.html" title="Intensive care unit">intensive care unit</a>. A less severe form is called acute lung injury (<b>ALI</b>).</p>
<p>ARDS formerly most commonly signified <i>adult respiratory distress syndrome</i> to differentiate it from <a href="../../../i/n/f/Infant_respiratory_distress_syndrome.html" title="Infant respiratory distress syndrome">infant respiratory distress syndrome</a> in premature infants. However, as this type of pulmonary edema also occurs in children, <i>ARDS</i> has gradually shifted to mean <i>acute</i> rather than <i>adult</i>. The differences with the typical infant syndrome remain.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Definition"><span class="tocnumber">1</span> <span class="toctext">Definition</span></a>
<ul>
<li class="toclevel-2"><a href="#Historical_background"><span class="tocnumber">1.1</span> <span class="toctext">Historical background</span></a></li>
<li class="toclevel-2"><a href="#Consensus_after_1967_and_1994"><span class="tocnumber">1.2</span> <span class="toctext">Consensus after 1967 and 1994</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Patient_presentation_and_diagnosis"><span class="tocnumber">2</span> <span class="toctext">Patient presentation and diagnosis</span></a></li>
<li class="toclevel-1"><a href="#Pathophysiology"><span class="tocnumber">3</span> <span class="toctext">Pathophysiology</span></a>
<ul>
<li class="toclevel-2"><a href="#Inflammation"><span class="tocnumber">3.1</span> <span class="toctext">Inflammation</span></a></li>
<li class="toclevel-2"><a href="#Mechanical_stress"><span class="tocnumber">3.2</span> <span class="toctext">Mechanical stress</span></a></li>
<li class="toclevel-2"><a href="#Progression"><span class="tocnumber">3.3</span> <span class="toctext">Progression</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Treatment"><span class="tocnumber">4</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2"><a href="#General"><span class="tocnumber">4.1</span> <span class="toctext">General</span></a></li>
<li class="toclevel-2"><a href="#Mechanical_ventilation"><span class="tocnumber">4.2</span> <span class="toctext">Mechanical ventilation</span></a></li>
<li class="toclevel-2"><a href="#APRV_.28Airway_Pressure_Release_Ventilation.29_and_ARDS_.2F_ALI"><span class="tocnumber">4.3</span> <span class="toctext">APRV (Airway Pressure Release Ventilation) and ARDS / ALI</span></a></li>
<li class="toclevel-2"><a href="#Positive_end-expiratory_pressure"><span class="tocnumber">4.4</span> <span class="toctext">Positive end-expiratory pressure</span></a></li>
<li class="toclevel-2"><a href="#Prone_position"><span class="tocnumber">4.5</span> <span class="toctext">Prone position</span></a></li>
<li class="toclevel-2"><a href="#Fluid_management"><span class="tocnumber">4.6</span> <span class="toctext">Fluid management</span></a></li>
<li class="toclevel-2"><a href="#Corticosteroids"><span class="tocnumber">4.7</span> <span class="toctext">Corticosteroids</span></a></li>
<li class="toclevel-2"><a href="#Nitric_oxide"><span class="tocnumber">4.8</span> <span class="toctext">Nitric oxide</span></a></li>
<li class="toclevel-2"><a href="#Surfactant_therapy"><span class="tocnumber">4.9</span> <span class="toctext">Surfactant therapy</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Complications"><span class="tocnumber">5</span> <span class="toctext">Complications</span></a></li>
<li class="toclevel-1"><a href="#Epidemiology"><span class="tocnumber">6</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">7</span> <span class="toctext">References</span></a>
<ul>
<li class="toclevel-2"><a href="#Further_reading"><span class="tocnumber">7.1</span> <span class="toctext">Further reading</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">8</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Definition" id="Definition"></a></p>
<h2><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: Definition">edit</a>]</span> <span class="mw-headline">Definition</span></h2>
<p><a name="Historical_background" id="Historical_background"></a></p>
<h3><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: Historical background">edit</a>]</span> <span class="mw-headline"><i>Historical background</i></span></h3>
<p>Acute respiratory distress syndrome was first described in 1967 by Ashbaugh <i>et al</i>.<sup id="_ref-Ashbaugh-ARDS_0" class="reference"><a href="#_note-Ashbaugh-ARDS" title="">[1]</a></sup> Initially there was no definition, resulting in controversy over <a href="../../../i/n/c/Incidence.html" title="Incidence">incidence</a> and <a href="../../../m/o/r/Mortality.html" title="Mortality">mortality</a>. In <a href="../../../1/9/8/1988.html" title="1988">1988</a> an expanded definition was proposed which quantified physiologic respiratory impairment.</p>
<p>In 1994 a new definition was recommended by the American-European Consensus Conference Committee.<sup id="_ref-definition-ARDS_0" class="reference"><a href="#_note-definition-ARDS" title="">[2]</a></sup> It had two advantages: 1 it recognizes that severity of pulmonary injury varies, 2 it is simple to use.<sup id="_ref-Review-ARDS_0" class="reference"><a href="#_note-Review-ARDS" title="">[3]</a></sup></p>
<p>ARDS was defined as the ratio of arterial partial oxygen tension (PaO<sub>2</sub>) as fraction of inspired oxygen <a href="../../../f/i/o/FiO2_3bff.html" title="FiO2">(FiO<sub>2</sub>)</a> below 200 mmHg in the presence of bilateral alveolar infiltrates on the chest x-ray. These infiltrates may appear similar to those of left ventricular failure, but the cardiac silhouette appears normal in ARDS. Also, the pulmonary capillary wedge pressure is normal (less than 18 mmHg) in ARDS, but raised in left ventricular failure.</p>
<p>A PaO<sub>2</sub>/FiO<sub>2</sub> ratio less than 300 mmHg with bilateral infiltrates indicates acute lung injury (ALI). Although formally considered different from ARDS, ALI is usually just a precursor to ARDS.</p>
<p><a name="Consensus_after_1967_and_1994" id="Consensus_after_1967_and_1994"></a></p>
<h3><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: Consensus after 1967 and 1994">edit</a>]</span> <span class="mw-headline"><i>Consensus after 1967 and 1994</i></span></h3>
<p>ARDS is characterized by:<sup id="_ref-definition-ARDS_1" class="reference"><a href="#_note-definition-ARDS" title="">[2]</a></sup></p>
<ul>
<li>Acute onset</li>
<li>Bilateral infiltrates on chest radiograph</li>
<li><a href="../../../p/u/l/Pulmonary_artery_wedge_pressure.html" title="Pulmonary artery wedge pressure">Pulmonary artery wedge pressure</a> &lt; 18 mmHg (obtained by <a href="../../../p/u/l/Pulmonary_artery_catheter.html" title="Pulmonary artery catheter">pulmonary artery catheterization</a>), if this information is available; if unavailable, then lack of clinical evidence of left ventricular failure suffices</li>
<li>if PaO<sub>2</sub>:FiO<sub>2</sub> &lt; 300 mmHg acute lung injury (ALI) is considered to be present</li>
<li>if PaO<sub>2</sub>:FiO<sub>2</sub> &lt; 200 mmHg acute respiratory distress syndrome (ARDS) is considered to be present</li>
</ul>
<p><a name="Patient_presentation_and_diagnosis" id="Patient_presentation_and_diagnosis"></a></p>
<h2><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: Patient presentation and diagnosis">edit</a>]</span> <span class="mw-headline">Patient presentation and diagnosis</span></h2>
<p>ARDS usually occurs within 24 to 48 hours of the initial injury or illness. The patient usually presents with <a href="../../../s/h/o/Shortness_of_breath.html" title="Shortness of breath">shortness of breath</a>, <a href="../../../t/a/c/Tachypnea.html" title="Tachypnea">tachypnea</a>, and symptoms related to the underlying cause, i.e. <a href="../../../s/h/o/Shock.html" title="Shock">shock</a>.</p>
<p>An <a href="../../../a/r/t/Arterial_blood_gas.html" title="Arterial blood gas">arterial blood gas</a> analysis and <a href="../../../c/h/e/Chest_X-ray_6e61.html" title="Chest X-ray">chest X-ray</a> allow formal diagnosis by inference using the aforementioned criteria. Although severe hypoxemia is generally included, the appropriate threshold defining abnormal PaO<sub>2</sub> has never been systematically studied.</p>
<p>Any cardiogenic cause of pulmonary edema should be excluded. This can be done by placing a <a href="../../../p/u/l/Pulmonary_artery_catheter.html" title="Pulmonary artery catheter">pulmonary artery catheter</a> for measuring the pulmonary artery wedge pressure. However, this is not necessary and is now rarely done as abundant evidence has emerged demonstrating that the use of pulmonary artery catheters does not lead to improved patient outcomes in critical illness including ARDS.</p>
<p>While CT scanning leads to more accurate images of the pulmonary parenchyma in ARDS, its has little utility in the clinical management of patients with ARDS, and remains largely a research tool. Plain Chest X-rays are sufficient to document bilateral alveolar infiltrates in the majority of cases.</p>
<p><a name="Pathophysiology" id="Pathophysiology"></a></p>
<h2><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: Pathophysiology">edit</a>]</span> <span class="mw-headline">Pathophysiology</span></h2>
<p>ARDS is characterized by a diffuse inflammation of lung parenchyma. The triggering insult to the parenchyma usually results in an initial release of <a href="../../../c/y/t/Cytokines.html" title="Cytokines">cytokines</a> and other inflammatory mediators, secreted by local <a href="../../../e/p/i/Epithelium.html" title="Epithelium">epithelial</a> and <a href="../../../e/n/d/Endothelium.html" title="Endothelium">endothelial</a> <a href="../../../c/e/l/Cell_%28biology%29.html" title="Cell (biology)">cells</a>.</p>
<p><a href="../../../n/e/u/Neutrophils.html" title="Neutrophils">Neutrophils</a> and some T-<a href="../../../l/y/m/Lymphocytes.html" title="Lymphocytes">lymphocytes</a> quickly migrate into the inflamed lung parynchema and contribute in the amplification of the phenomenon.</p>
<p>Typical histological presentation involves diffuse <a href="../../../p/u/l/Pulmonary_alveolus.html" title="Pulmonary alveolus">alveolar</a> damage and <a href="../../../h/y/a/Hyaline.html" title="Hyaline">hyaline</a> membrane formation in alveolar walls.</p>
<p>Although the triggering mechanisms are not completely understood, recent research has examined the role of inflammation and mechanical stress.</p>
<p><a name="Inflammation" id="Inflammation"></a></p>
<h3><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: Inflammation">edit</a>]</span> <span class="mw-headline">Inflammation</span></h3>
<p>Inflammation alone, as in sepsis, causes endothelial dysfunction, fluid extravasation from the <a href="../../../c/a/p/Capillary.html" title="Capillary">capillaries</a> and impaired drainage of fluid from the lungs. Dysfunction of type II pulmonary epithelial cells may also be present, with a concomitant reduction in <a href="../../../s/u/r/Surfactant.html" title="Surfactant">surfactant</a> production. Elevated inspired oxygen concentration often become necessary at this stage, and they may facilitate a '<a href="../../../r/e/s/Respiratory_burst.html" title="Respiratory burst">respiratory burst</a>' in immune cells.</p>
<p>In a secondary phase, endothelial dysfunction causes cells and inflammatory exudate to enter the alveoli. This <a href="../../../p/u/l/Pulmonary_edema.html" title="Pulmonary edema">pulmonary edema</a> increases the thickness of the alveolo-capillary space, increasing the distance the <a href="../../../o/x/y/Oxygen.html" title="Oxygen">oxygen</a> must diffuse to reach <a href="../../../b/l/o/Blood.html" title="Blood">blood</a>. This impairs gas exchange leading to hypoxia, increases the work of breathing, eventually induces <a href="../../../f/i/b/Fibrosis.html" title="Fibrosis">fibrosis</a> of the airspace.</p>
<p>Moreover, edema and decreased surfactant production by type II pneumocytes may cause whole <a href="../../../p/u/l/Pulmonary_alveolus.html" title="Pulmonary alveolus">alveoli</a> to collapse, or to completely flood. This <i>loss of aeration</i>, is contributes further to the right-to-left <a href="../../../s/h/u/Shunt.html" title="Shunt">shunt</a> in ARDS. As the alveoli contain progressively less gas, more blood flows through them without being oxygenated.</p>
<p>Collapsed alveoli (and small <a href="../../../b/r/o/Bronchi.html" title="Bronchi">bronchi</a>) do not allow gas exchange. It is not uncommon to see patients with a PaO<sub>2</sub> of 60 <a href="../../../m/m/h/MmHg_330d.html" title="MmHg">mmHg</a> (8.0 <a href="../../../k/i/l/Kilopascal.html" title="Kilopascal">kPa</a>) despite mechanical ventilation with 100% inspired oxygen.</p>
<p>The loss of aeration may follow different patterns according to the nature of the underlying disease, and other factors. In pneumonia-induced ARDS, for example, large, more commonly causes relatively compact areas of alveolar infiltrates. These are usually distributed to the lower <a href="../../../l/o/b/Lobe.html" title="Lobe">lobes</a>, in their posterior segments, and they roughly correspond to the initial infected area.</p>
<p>In sepsis or trauma-induced ARDS, infiltrates are usually more patchy and diffuse. The posterior and basal segments are always more affected, but the distribution is even less homogeneous.</p>
<p>Loss of aeration also causes important changes in lung mechanical properties. These alterations are fundamental in the process of inflammation amplification and progression to ARDS in mechanically ventilated patients.</p>
<p><a name="Mechanical_stress" id="Mechanical_stress"></a></p>
<h3><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: Mechanical stress">edit</a>]</span> <span class="mw-headline">Mechanical stress</span></h3>
<p><a href="../../../m/e/c/Mechanical_ventilation.html" title="Mechanical ventilation">Mechanical ventilation</a> is an essential part of the treatment of ARDS. As loss of aeration (and the underlying disease) progress, the work of breathing (WOB) eventually grows to a level incompatible with life. Thus, mechanical ventilation is initiated to relieve respiratory muscles of their work, and to protect the usually obtunded patient's <a href="../../../a/i/r/Airway.html" title="Airway">airways</a>.</p>
<p>However, mechanical ventilation may constitute a risk factor for the development, or the worsening, of ARDS.</p>
<p>Aside from the infectious complications arising from invasive ventilation with tracheal <a href="../../../i/n/t/Intubation.html" title="Intubation">intubation</a>, positive-pressure ventilation directly alters lung mechanics during ARDS. The result is higher mortality, when injudicious techniques are used.</p>
<p>In 1998, Amato <i>et al</i> published a paper showing substantial improvement in the outcome of patients ventilated with lower <a href="../../../t/i/d/Tidal_volume.html" title="Tidal volume">tidal volumes</a> (<i>V</i><sub>t</sub>) (6 mL·kg<sup>-1</sup>).<sup id="_ref-Amato_1998_0" class="reference"><a href="#_note-Amato_1998" title="">[4]</a></sup> This result was confirmed in a 2000 study sponsored by the <a href="../../../n/a/t/National_Institutes_of_Health_5b2b.html" title="National Institutes of Health">NIH</a>.<sup id="_ref-MacIntyre_2000_0" class="reference"><a href="#_note-MacIntyre_2000" title="">[5]</a></sup> Although both these studies were widely criticized for several reasons, and although the authors were not the first to experiment lower-volume ventilation, they shed new light on the relationship between mechanical ventilation and ARDS.</p>
<p>One opinion is that the forces applied to the lung by the <a href="../../../v/e/n/Ventilator.html" title="Ventilator">ventilator</a> may work as a lever to induce further damage to lung parenchyma. It appears that <a href="../../../s/h/e/Shear_stress.html" title="Shear stress">shear stress</a> at the <a href="../../../i/n/t/Interface_%28chemistry%29.html" title="Interface (chemistry)">interface</a> between collapsed and aerated units may result in the breakdown of aerated units, which inflate asymmetrically due to the 'stickiness' of surrounding flooded alveoli. The fewer such interfaces around an alveolus, the lesser the stress.</p>
<p>Indeed, even relatively low stress forces may induce <a href="../../../s/i/g/Signal_transduction.html" title="Signal transduction">signal transduction</a> systems at the cellular level, thus inducing the release of inflammatory mediators.</p>
<p>This form of stress is thought to be applied by the transpulmonary pressure (<a href="../../../g/r/a/Gradient.html" title="Gradient">gradient</a>) (<i>P</i><sub>l</sub>) generated by the ventilator or, better, its cyclical variations. The better outcome obtained in patients ventilated with lower <i>V</i><sub>t</sub> may be interpreted as a beneficial effect of the lower <i>P</i><sub>l</sub>. Transpulmonary <a href="../../../p/r/e/Pressure.html" title="Pressure">pressure</a>, is an indirect <a href="../../../f/u/n/Function_%28mathematics%29.html" title="Function (mathematics)">function</a> of the <i>V</i><sub>t</sub> setting on the ventilator, and only trial patients with plateau pressures (a surrogate for the actual <i>P</i><sub>l</sub>) were less than 32 <a href="../../../c/e/n/Centimetre_of_water.html" title="Centimetre of water">cmH<sub>2</sub>O</a> (3.1 <a href="../../../k/i/l/Kilopascal.html" title="Kilopascal">kPa</a>) had improved survival.</p>
<p>The way <i>P</i><sub>l</sub> is applied on alveolar surface determines the shear stress to which lung units are exposed. ARDS is characterized by an usually inhomogeneous reduction of the airspace, and thus by a tendency towards higher <i>P</i><sub>l</sub> at the same <i>V</i><sub>t</sub>, and towards <i>higher</i> stress on <i>less</i> diseased units.</p>
<p>The inhomogeneity of alveoli at different stages of disease is further increased by the gravitational gradient to which they are exposed, and the different <a href="../../../p/e/r/Perfusion_pressure.html" title="Perfusion pressure">perfusion pressures</a> at which blood flows through them. Finally, abdominal pressure exerts an additional pressure on infero-posterior lung segments, favoring compression and collapse of those units.</p>
<p>The different mechanical properties of alveoli in ARDS may be interpreted as having varying <i>time constants</i> (the product of alveolar <a href="../../../c/o/m/Compliance.html" title="Compliance">compliance</a> × <a href="../../../p/u/l/Pulmonary_alveolus.html#details" title="Pulmonary alveolus">resistance</a>). A long time constant indicates an alveolus which opens slowly during tidal inflation, as a consequence of contrasting pressure around it, or altered water-air interface inside it (loss of surfactant, flooding).</p>
<p>Slow alveoli are said to be 'kept open' using <a href="../../../m/e/c/Mechanical_ventilation.html" title="Mechanical ventilation">positive end-expiratory pressure</a>, a feature of modern ventilators which maintains a positive airway pressure throughout the whole respiratory cycle. A higher mean pressure cycle-wide slows the collapse of diseased units, but it has to be weighed against the corresponding elevation in <i>P</i><sub>l</sub>/plateau pressure.</p>
<p>The prone position also reduces the inhomogeneity in alveolar time constants induced gravity and edema.</p>
<p><a name="Progression" id="Progression"></a></p>
<h3><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: Progression">edit</a>]</span> <span class="mw-headline">Progression</span></h3>
<p>If the underlying disease or injurious factor is not removed, the amount of inflammatory mediators released by the lungs in ARDS may result in a <a href="../../../s/y/s/Systemic_inflammatory_response_syndrome.html" title="Systemic inflammatory response syndrome">systemic inflammatory response syndrome</a> (or sepsis if there is lung infection). The evolution towards <a href="../../../s/h/o/Shock.html" title="Shock">shock</a> and/or <a href="../../../m/u/l/Multiple_organ_failure.html" title="Multiple organ failure">multiple organ failure</a> follows paths analogous to the pathophysiology of sepsis.</p>
<p>This adds up to the impaired oxygenation, the real mainstay of ARDS, and <a href="../../../r/e/s/Respiratory_acidosis.html" title="Respiratory acidosis">respiratory acidosis</a>, often caused by the ventilation techniques indicated in ARDS.</p>
<p>The result is a critical illness in which the 'endothelial disease' of severe sepsis/<a href="../../../s/i/r/SIRS_45d3.html" title="SIRS">SIRS</a> is worsened by the pulmonary dysfunction, which further impairs oxygen delivery.</p>
<p><a name="Treatment" id="Treatment"></a></p>
<h2><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: Treatment">edit</a>]</span> <span class="mw-headline">Treatment</span></h2>
<p><a name="General" id="General"></a></p>
<h3><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: General">edit</a>]</span> <span class="mw-headline">General</span></h3>
<p>Acute respiratory distress syndrome is usually treated with <a href="../../../m/e/c/Mechanical_ventilation.html" title="Mechanical ventilation">mechanical ventilation</a> in the <a href="../../../i/n/t/Intensive_care.html" title="Intensive care">Intensive Care Unit</a>. Ventilation is usually delivered through oro-tracheal <a href="../../../i/n/t/Intubation.html" title="Intubation">intubation</a>, or <a href="../../../t/r/a/Tracheotomy.html" title="Tracheotomy">tracheostomy</a> whenever prolonged ventilation (≥2 weeks) is deemed inevitable.</p>
<p>The possibilities of non-invasive ventilation are limited to the very early period of the disease or, better, to prevention in individuals at risk for the development of the disease (<a href="../../../a/t/y/Atypical_pneumonia.html" title="Atypical pneumonia">atypical pneumonias</a>, pulmonary contusion, major surgery patients).</p>
<p>Treatment of the underlying cause is imperative, as it tends to maintain the ARDS picture.</p>
<p>Appropriate <a href="../../../a/n/t/Antibiotic.html" title="Antibiotic">antibiotic</a> therapy must be administered as soon as <a href="../../../m/i/c/Microbiological_culture.html" title="Microbiological culture">microbiological culture</a> results are available. <a href="../../../e/m/p/Empirical.html" title="Empirical">Empirical</a> therapy <i>may</i> be appropriate if local microbiological surveillance is efficient. More than 60% ARDS patients experience a (<a href="../../../n/o/s/Nosocomial.html" title="Nosocomial">nosocomial</a>) pulmonary infection either before or after the onset of lung injury.</p>
<p>The origin of <a href="../../../i/n/f/Infection.html" title="Infection">infection</a>, when surgically treatable, must be operated on. When <a href="../../../s/e/p/Sepsis.html" title="Sepsis">sepsis</a> is diagnosed, appropriate local <a href="../../../g/u/i/Guideline_%28medical%29.html" title="Guideline (medical)">protocols</a> should be enacted.</p>
<p>Commonly used supportive therapy includes particular techniques of mechanical ventilation and pharmacological agents whose effectiveness with respect to the outcome has not yet been proven. It is now debated whether mechanical ventilation is to be considered mere supportive therapy or actual treatment, since it may substantially affect survival.</p>
<p><a name="Mechanical_ventilation" id="Mechanical_ventilation"></a></p>
<h3><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: Mechanical ventilation">edit</a>]</span> <span class="mw-headline">Mechanical ventilation</span></h3>
<dl>
<dd><i>Further information: <a href="../../../p/r/e/Pressure_Regulated_Volume_Control_84d8.html" title="Pressure Regulated Volume Control">Pressure Regulated Volume Control</a></i></dd>
</dl>
<p>The overall goal is to maintain acceptable gas exchange and to minimize adverse effects in its application. Three parameters are used: PEEP (positive end-expiratory pressure, to maintain maximal recruitment of alveolar units), mean airway pressure (to promote recruitment and predictor of hemodynamic effects) and plateau pressure (best predictor of alveolar overdistention).</p>
<p>Conventional therapy aimed at <a href="../../../t/i/d/Tidal_volume.html" title="Tidal volume">tidal volumes</a> (<i>V</i><sub>t</sub>) of 12-15 ml/kg. Recent studies have shown that high tidal volumes can overstretch alveoli resulting in volutrauma (secondary lung injury). The ARDS Clinical Network, or <a href="http://www.ardsnet.org/index.php" class="external text" title="http://www.ardsnet.org/index.php" rel="nofollow">ARDSNet</a>, completed a landmark trial that showed improved <a href="../../../m/o/r/Mortality.html" title="Mortality">mortality</a> when ventilated with a tidal volume of 6 ml/kg compared to the traditional 12 ml/kg. Low tidal volumes (<i>V</i><sub>t</sub>) may cause <a href="../../../h/y/p/Hypercapnia.html" title="Hypercapnia">hypercapnia</a> and <a href="../../../a/t/e/Atelectasis.html" title="Atelectasis">atelectasis</a>.<sup id="_ref-Rippe-ARDS_0" class="reference"><a href="#_note-Rippe-ARDS" title="">[6]</a></sup></p>
<p>Low tidal volume ventilation was the primary independent variable associated with reduced mortality in the NIH-sponsored ARDSnet trial of tidal volume in ARDS. Plateau pressure less than 30 cm H2O was a secondary goal, and subsequent analyses of the data from the ARDSnet trial (as well as other experimental data) demonsrtate that there appears to be NO safe upper limit to plateau pressure; that is, regardless of plateau pressure, patients fare better with low tidal volumes (see Hager et al, American Journal of Respiratory and Critical Care Medicine, 2005).</p>
<p><a name="APRV_.28Airway_Pressure_Release_Ventilation.29_and_ARDS_.2F_ALI" id="APRV_.28Airway_Pressure_Release_Ventilation.29_and_ARDS_.2F_ALI"></a></p>
<h3><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: APRV (Airway Pressure Release Ventilation) and ARDS / ALI">edit</a>]</span> <span class="mw-headline">APRV (Airway Pressure Release Ventilation) and ARDS / ALI</span></h3>
<p>Although a particular ventilation mode has yet to be "proven in clinical trials"* more effective than others in treating patients with ARDS, ever increasing empirical evidence and clinical experience is showing that <a href="http://www.aacn.org/pdfLibra.NSF/Files/ci120205/$file/ci120205.pdf" class="external text" title="http://www.aacn.org/pdfLibra.NSF/Files/ci120205/$file/ci120205.pdf" rel="nofollow">APRV</a>is the primary mode of choice when ventilating a patient with ARDS or ALI (Acute Lung Injury).</p>
<p>Advantages to APRV ventilation include: decreased airway pressures, decreased minute ventilation, decreased dead-space ventilation, promotion of spontaneous breathing, almost 24 hour a day alveolar recruitment, decreased use of sedation, near elimination of neuromuscular blockade and an often positive effect on cardiac output (due to the negative inflection from the elevated baseline with each spontaneous breath).</p>
<p>A patient with ARDS on average spends 8 to 11 days on a mechanical ventilator; APRV may reduce this time significantly.</p>
<ul>
<li>*This would require a side by side study of APRV and the current ARDSNet protocol. There seems to be little political will, within the medical community, to address the need for this study, in spite of the successes seen with APRV.</li>
</ul>
<p><a name="Positive_end-expiratory_pressure" id="Positive_end-expiratory_pressure"></a></p>
<h3><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: Positive end-expiratory pressure">edit</a>]</span> <span class="mw-headline">Positive end-expiratory pressure</span></h3>
<p><a href="../../../p/o/s/Positive_end-expiratory_pressure.html" title="Positive end-expiratory pressure">Positive end-expiratory pressure</a> (PEEP) must be used in mechanically-ventilated patients in order to contrast the tendency to collapse of affected alveoli.</p>
<p>Ideally, a 'perfect' PEEP would match the increased alveolar <a href="../../../s/u/r/Surface_tension.html" title="Surface tension">surface tension</a>, caused by surfactant deficiency and external pressure (edema), thus restoring a normal time constant in all affected units.</p>
<p>However, because of the cited inherent inhomogeneity, surface tension varies, and so do PEEP requirements for the diseased units. Furthermore, high levels of PEEP may impair <a href="../../../v/e/n/Venous_blood.html" title="Venous blood">venous blood</a> return to the right <a href="../../../h/e/a/Heart.html" title="Heart">heart</a>, although the actual impact of PEEP on <a href="../../../h/e/m/Hemodynamics.html" title="Hemodynamics">hemodynamics</a> is still debated.</p>
<p>The 'best PEEP' used to be defined as 'some' cmH<sub>2</sub>O above the lower inflection point (LIP) in the <a href="../../../s/i/g/Sigmoidal.html" title="Sigmoidal">sigmoidal</a> pressure-volume relationship curve of the lung. Recent research has shown that the LIP-point pressure is no better than any pressure above it, as recruitment of collapsed alveoli, and more importantly the overdistention of aerated units, occur throughout the whole inflation. Despite the awkwardness of most procedures used to trace the pressure-volume curve, it is still used by some to define the <i>minimum</i> PEEP to be applied to their patients. Some of the newest ventilators have the ability to automatically plot a pressure-volume curve. The possibility of having an 'instantaneous' tracing trigger might produce renewed interest in this analysis.</p>
<p>PEEP may also be set empirically. Some authors suggest performing a 'recruiting maneuver' (i.e., a short time at a very high continuous positive airway pressure, such as 50 cmH<sub>2</sub>O (4.9 kPa), to recruit, or open, collapsed unit with a high distending pressure) and then to increase PEEP to a rather high level before restoring previous ventilation. The final PEEP level should be the one just before the drop in PaO<sub>2</sub> (or <a href="../../../h/e/m/Hemoglobin.html" title="Hemoglobin">peripheral blood oxygen saturation</a>) during a step-down trial.</p>
<p>PEEP 'stacks up' to P<sub>l</sub> during volume-controlled ventilation. At high levels, it may cause significant overdistension of (and injury to) compliant, aerated units, and higher plateau pressures at the same <i>V</i><sub>t</sub>.</p>
<p>Intrinsic PEEP (iPEEP), or auto-PEEP, is not detected during normal ventilation. However, when ventilating at high frequencies, its contribution may be substantial, both in its positive and negative effects. There are 'underground', unproven claims that the Amato and NIH/ARDS Network studies got a positive result because of the high iPEEP levels reached by spontaneously breathing patients in low-volume assist-control ventilation. Whether or not that is true, it is a fact that iPEEP has been measured in very few formal studies on ventilation in ARDS patients, and its entity is largely unknown. Its measurement is recommended in the treatment of ARDS patients, especially when using <a href="../../../h/i/g/High-frequency_ventilation.html" title="High-frequency ventilation">high-frequency (oscillatory/jet) ventilation</a>.</p>
<p>A compromise between the beneficial and adverse effects of PEEP is, as usual, inevitable.</p>
<p><a name="Prone_position" id="Prone_position"></a></p>
<h3><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: Prone position">edit</a>]</span> <span class="mw-headline">Prone position</span></h3>
<p>Distribution of lung infiltrates in acute respiratory distress syndrome is non-uniform. Repositioning into the prone position (face down) might improve oxygenation by relieving <a href="../../../a/t/e/Atelectasis.html" title="Atelectasis">atelectasis</a> and improving perfusion. However, although the hypoxemia is overcome there seems to be no effect on overall survival.<sup id="_ref-Prone-ARDS_0" class="reference"><a href="#_note-Prone-ARDS" title="">[7]</a></sup><sup id="_ref-Rippe-ARDS_1" class="reference"><a href="#_note-Rippe-ARDS" title="">[6]</a></sup></p>
<p><a name="Fluid_management" id="Fluid_management"></a></p>
<h3><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: Fluid management">edit</a>]</span> <span class="mw-headline">Fluid management</span></h3>
<p>Several studies have shown that pulmonary function and outcome are better in patients that lost weight or wedge pressure was lowered by <a href="../../../d/i/u/Diuresis.html" title="Diuresis">diuresis</a> or fluid restriction.<sup id="_ref-Rippe-ARDS_2" class="reference"><a href="#_note-Rippe-ARDS" title="">[6]</a></sup></p>
<p><a name="Corticosteroids" id="Corticosteroids"></a></p>
<h3><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: Corticosteroids">edit</a>]</span> <span class="mw-headline">Corticosteroids</span></h3>
<p>Patients with ARDS do not benefit from high-dose corticosteroids. Meduri et al however did find significant improvement using modest doses. This is probably because of a suppression of ongoing inflammation during the fibroproliferative phase of ARDS. The initial regimen consists of <a href="../../../m/e/t/Methylprednisolone.html" title="Methylprednisolone">methylprednisolone</a> 2 mg/kg daily. After 3-5 days a response must be apparent. In 1-2 weeks the dose can be tapered to methylprednisolone 0.5-1.0 mg daily. In the absence of results steroids can be discontinued.<sup id="_ref-Meduri-ARDS_0" class="reference"><a href="#_note-Meduri-ARDS" title="">[8]</a></sup><sup id="_ref-Rippe-ARDS_3" class="reference"><a href="#_note-Rippe-ARDS" title="">[6]</a></sup></p>
<p>The recent NIH-sponsored ARDSnet LAZARUS study of corticosteroids for ARDS demonstrated that they are not efficacious in ARDS.</p>
<p><a name="Nitric_oxide" id="Nitric_oxide"></a></p>
<h3><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: Nitric oxide">edit</a>]</span> <span class="mw-headline">Nitric oxide</span></h3>
<p>Inhaled <a href="../../../n/i/t/Nitric_oxide.html" title="Nitric oxide">nitric oxide</a> (NO) potentially acts as selective pulmonary vasodilator. Rapid binding to <a href="../../../h/e/m/Hemoglobin.html" title="Hemoglobin">hemoglobin</a> prevents systemic effects. It should increase perfusion of better ventilated areas. There are no large studies demonstrating positive results. Therefore its use must be considered individually.</p>
<p>Almitrine bismesylate stimulates chemoreceptors in carotic and aortic bodies. It has been used to potentiate the effect of NO, presumably by potentiating hypoxia-induced pulmonary vasoconstriction. In case of ARDS it is not known whether this combination is useful.<sup id="_ref-Rippe-ARDS_4" class="reference"><a href="#_note-Rippe-ARDS" title="">[6]</a></sup></p>
<p><a name="Surfactant_therapy" id="Surfactant_therapy"></a></p>
<h3><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: Surfactant therapy">edit</a>]</span> <span class="mw-headline">Surfactant therapy</span></h3>
<p>To date no prospective <a href="../../../r/a/n/Randomized_controlled_trial.html" title="Randomized controlled trial">controlled clinical trial</a> has shown a significant mortality benefit of exogenous surfactant in ARDS.<sup id="_ref-Rippe-ARDS_5" class="reference"><a href="#_note-Rippe-ARDS" title="">[6]</a></sup></p>
<p><a name="Complications" id="Complications"></a></p>
<h2><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: Complications">edit</a>]</span> <span class="mw-headline">Complications</span></h2>
<p>Since ARDS is an extremely serious condition which requires invasive forms of therapy it is not without risk. Complications to be considered are:<sup id="_ref-Rippe-ARDS_6" class="reference"><a href="#_note-Rippe-ARDS" title="">[6]</a></sup></p>
<ul>
<li>Pulmonary: <a href="../../../b/a/r/Barotrauma.html" title="Barotrauma">barotrauma</a> (volutrauma), <a href="../../../p/u/l/Pulmonary_embolism.html" title="Pulmonary embolism">pulmonary embolism</a> (PE), pulmonary fibrosis, <a href="../../../v/e/n/Ventilator-associated_pneumonia.html" title="Ventilator-associated pneumonia">ventilator-associated pneumonia</a> (VAP).</li>
<li>Gastrointestinal: hemorrhage (ulcer), dysmotility, pneumoperitoneum, bacterial translocation.</li>
<li>Cardiac: arrhytmias, myocardial dysfunction.</li>
<li>Renal: <a href="../../../a/c/u/Acute_renal_failure.html" title="Acute renal failure">acute renal failure</a> (ARF), positive fluid balance.</li>
<li>Mechanical: vascular injury, pneumothorax (by placing pulmonary artery catheter), tracheal injury/stenosis (result of intubation and/or irritation by endotracheal tube.</li>
<li>Nutritional: malnutrition (katabolic state), electrolyte deficiency.</li>
</ul>
<p><a name="Epidemiology" id="Epidemiology"></a></p>
<h2><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: Epidemiology">edit</a>]</span> <span class="mw-headline">Epidemiology</span></h2>
<p>The annual incidence of ARDS is between 1.5 to 13.5 people per 100,000 in the general population. Its incidence in the <a href="../../../i/n/t/Intensive_care_unit.html" title="Intensive care unit">intensive care unit</a> (ICU), <a href="../../../m/e/c/Mechanical_ventilation.html" title="Mechanical ventilation">mechanically ventilated</a> population is much higher. Brun-Buisson <i>et al.</i> (2004) reported a prevalence of acute lung injury (ALI) (see below) of 16.1% percent in ventilated patients admitted for more than 4 hours. More than half these patients may develop ARDS.</p>
<p><a href="../../../m/e/c/Mechanical_ventilation.html" title="Mechanical ventilation">Mechanical ventilation</a>, <a href="../../../s/e/p/Sepsis.html" title="Sepsis">sepsis</a>, <a href="../../../p/n/e/Pneumonia.html" title="Pneumonia">pneumonia</a>, <a href="../../../s/h/o/Shock.html" title="Shock">shock</a>, <a href="../../../p/u/l/Pulmonary_aspiration.html" title="Pulmonary aspiration">aspiration</a>, <a href="../../../p/h/y/Physical_trauma.html" title="Physical trauma">trauma</a> (especially pulmonary contusion), <a href="../../../s/u/r/Surgery.html" title="Surgery">major surgery</a>, massive <a href="../../../b/l/o/Blood_transfusion.html" title="Blood transfusion">transfusions</a>, <a href="../../../s/m/o/Smoke_inhalation.html" title="Smoke inhalation">smoke inhalation</a>, drug reaction or <a href="../../../o/v/e/Overdose.html" title="Overdose">overdose</a>, fat emboli and reperfusion pulmonary edema after <a href="../../../l/u/n/Lung_transplantation.html" title="Lung transplantation">lung transplantation</a> or pulmonary embolectomy may all trigger ARDS. Pneumonia and sepsis are the most common triggers, and pneumonia is present in up to 60% of patients. Pneumonia and sepsis may be either causes or complications of ARDS.</p>
<p>Elevated abdominal pressure of any cause is also probably a risk factor for the development of ARDS, particularly during mechanical ventilation.</p>
<p><a href="../../../m/o/r/Mortality.html" title="Mortality">Mortality</a> varies from 30% to 60%. Usually, <a href="../../../r/a/n/Randomized_controlled_trials.html" title="Randomized controlled trials">randomized controlled trials</a> in the literature show lower death rates, both in control and treatment patients. This is thought to be due to stricter enrollment criteria. Observational studies generally report 50%-60% mortality.</p>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small" style="-moz-column-count:2; column-count:2};">
<ol class="references">
<li id="_note-Ashbaugh-ARDS"><b><a href="#_ref-Ashbaugh-ARDS_0" title="">^</a></b> <cite style="font-style:normal">Ashbaugh D, Bigelow D, Petty T, Levine B (1967). "Acute respiratory distress in adults.". <i>Lancet</i> <b>2</b> (7511): 319-23. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=4143721" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=4143721">PMID 4143721</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Acute+respiratory+distress+in+adults.&amp;rft.title=Lancet&amp;rft.jtitle=Lancet&amp;rft.date=1967&amp;rft.volume=2&amp;rft.issue=7511&amp;rft.au=Ashbaugh+D%2C+Bigelow+D%2C+Petty+T%2C+Levine+B&amp;rft.pages=319-23">&#160;</span></li>
<li id="_note-definition-ARDS">^ <a href="#_ref-definition-ARDS_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-definition-ARDS_1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal">Bernard G, Artigas A, Brigham K, Carlet J, Falke K, Hudson L, Lamy M, Legall J, Morris A, Spragg R (1994). "The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.". <i>Am J Respir Crit Care Med</i> <b>149</b> (3 Pt 1): 818-24. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7509706" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7509706">PMID 7509706</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=The+American-European+Consensus+Conference+on+ARDS.+Definitions%2C+mechanisms%2C+relevant+outcomes%2C+and+clinical+trial+coordination.&amp;rft.title=Am+J+Respir+Crit+Care+Med&amp;rft.jtitle=Am+J+Respir+Crit+Care+Med&amp;rft.date=1994&amp;rft.volume=149&amp;rft.issue=3+Pt+1&amp;rft.au=Bernard+G%2C+Artigas+A%2C+Brigham+K%2C+Carlet+J%2C+Falke+K%2C+Hudson+L%2C+Lamy+M%2C+Legall+J%2C+Morris+A%2C+Spragg+R&amp;rft.pages=818-24">&#160;</span></li>
<li id="_note-Review-ARDS"><b><a href="#_ref-Review-ARDS_0" title="">^</a></b> <cite style="font-style:normal">Ware L, Matthay M (2000). "The acute respiratory distress syndrome.". <i>N Engl J Med</i> <b>342</b> (18): 1334-49. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10793167" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10793167">PMID 10793167</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=The+acute+respiratory+distress+syndrome.&amp;rft.title=N+Engl+J+Med&amp;rft.jtitle=N+Engl+J+Med&amp;rft.date=2000&amp;rft.volume=342&amp;rft.issue=18&amp;rft.au=Ware+L%2C+Matthay+M&amp;rft.pages=1334-49">&#160;</span></li>
<li id="_note-Amato_1998"><b><a href="#_ref-Amato_1998_0" title="">^</a></b> <cite style="font-style:normal">Amato M, Barbas C, Medeiros D, Magaldi R, Schettino G, Lorenzi-Filho G, Kairalla R, Deheinzelin D, Munoz C, Oliveira R, Takagaki T, Carvalho C (1998). "Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome.". <i>N Engl J Med</i> <b>338</b> (6): 347-54. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9449727" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9449727">PMID 9449727</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Effect+of+a+protective-ventilation+strategy+on+mortality+in+the+acute+respiratory+distress+syndrome.&amp;rft.title=N+Engl+J+Med&amp;rft.jtitle=N+Engl+J+Med&amp;rft.date=1998&amp;rft.volume=338&amp;rft.issue=6&amp;rft.au=Amato+M%2C+Barbas+C%2C+Medeiros+D%2C+Magaldi+R%2C+Schettino+G%2C+Lorenzi-Filho+G%2C+Kairalla+R%2C+Deheinzelin+D%2C+Munoz+C%2C+Oliveira+R%2C+Takagaki+T%2C+Carvalho+C&amp;rft.pages=347-54">&#160;</span></li>
<li id="_note-MacIntyre_2000"><b><a href="#_ref-MacIntyre_2000_0" title="">^</a></b> <cite style="font-style:normal">MacIntyre N (2000). "Mechanical ventilation strategies for lung protection.". <i>Semin Respir Crit Care Med</i> <b>21</b> (3): 215-22. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16088734" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16088734">PMID 16088734</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Mechanical+ventilation+strategies+for+lung+protection.&amp;rft.title=Semin+Respir+Crit+Care+Med&amp;rft.jtitle=Semin+Respir+Crit+Care+Med&amp;rft.date=2000&amp;rft.volume=21&amp;rft.issue=3&amp;rft.au=MacIntyre+N&amp;rft.pages=215-22">&#160;</span></li>
<li id="_note-Rippe-ARDS">^ <a href="#_ref-Rippe-ARDS_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-Rippe-ARDS_1" title=""><sup><i><b>b</b></i></sup></a> <a href="#_ref-Rippe-ARDS_2" title=""><sup><i><b>c</b></i></sup></a> <a href="#_ref-Rippe-ARDS_3" title=""><sup><i><b>d</b></i></sup></a> <a href="#_ref-Rippe-ARDS_4" title=""><sup><i><b>e</b></i></sup></a> <a href="#_ref-Rippe-ARDS_5" title=""><sup><i><b>f</b></i></sup></a> <a href="#_ref-Rippe-ARDS_6" title=""><sup><i><b>g</b></i></sup></a> <cite class="book" style="font-style:normal">Irwin RS, Rippe JM (2003). <i>Irwin and Rippe's Intensive Care Medicine</i>, 5th ed., Lippincott Williams &amp; Wilkins. <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0-7817-3548-3</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Irwin+and+Rippe%27s+Intensive+Care+Medicine&amp;rft.title=Irwin+and+Rippe%27s+Intensive+Care+Medicine&amp;rft.au=Irwin+RS%2C+Rippe+JM&amp;rft.date=2003&amp;rft.edition=5th+ed.&amp;rft.pub=Lippincott+Williams+%26+Wilkins">&#160;</span></li>
<li id="_note-Prone-ARDS"><b><a href="#_ref-Prone-ARDS_0" title="">^</a></b> <cite style="font-style:normal">Gattinoni L, Tognoni G, Pesenti A, Taccone P, Mascheroni D, Labarta V, Malacrida R, Di Giulio P, Fumagalli R, Pelosi P, Brazzi L, Latini R (2001). "Effect of prone positioning on the survival of patients with acute respiratory failure.". <i>N Engl J Med</i> <b>345</b> (8): 568-73. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11529210" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11529210">PMID 11529210</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Effect+of+prone+positioning+on+the+survival+of+patients+with+acute+respiratory+failure.&amp;rft.title=N+Engl+J+Med&amp;rft.jtitle=N+Engl+J+Med&amp;rft.date=2001&amp;rft.volume=345&amp;rft.issue=8&amp;rft.au=Gattinoni+L%2C+Tognoni+G%2C+Pesenti+A%2C+Taccone+P%2C+Mascheroni+D%2C+Labarta+V%2C+Malacrida+R%2C+Di+Giulio+P%2C+Fumagalli+R%2C+Pelosi+P%2C+Brazzi+L%2C+Latini+R&amp;rft.pages=568-73">&#160;</span></li>
<li id="_note-Meduri-ARDS"><b><a href="#_ref-Meduri-ARDS_0" title="">^</a></b> <cite style="font-style:normal">Meduri G, Tolley E, Chrousos G, Stentz F (2002). "Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids.". <i>Am J Respir Crit Care Med</i> <b>165</b> (7): 983-91. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11934726" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11934726">PMID 11934726</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Prolonged+methylprednisolone+treatment+suppresses+systemic+inflammation+in+patients+with+unresolving+acute+respiratory+distress+syndrome%3A+evidence+for+inadequate+endogenous+glucocorticoid+secretion+and+inflammation-induced+immune+cell+resistance+to+glucocorticoids.&amp;rft.title=Am+J+Respir+Crit+Care+Med&amp;rft.jtitle=Am+J+Respir+Crit+Care+Med&amp;rft.date=2002&amp;rft.volume=165&amp;rft.issue=7&amp;rft.au=Meduri+G%2C+Tolley+E%2C+Chrousos+G%2C+Stentz+F&amp;rft.pages=983-91">&#160;</span></li>
</ol>
</div>
<p><a name="Further_reading" id="Further_reading"></a></p>
<h3><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: Further reading">edit</a>]</span> <span class="mw-headline">Further reading</span></h3>
<div class="references-small" style="-moz-column-count:2; column-count:2;">
<ul>
<li>Martin GS, Moss M, Wheeler AP, Mealer M, Morris JA, Bernard GR. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med. 2005 Aug;33(8):1681-1687. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16096441" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16096441">PMID 16096441</a>.</li>
<li>Jackson WL Jr, Shorr AF. Blood transfusion and the development of acute respiratory distress syndrome: more evidence that blood transfusion in the intensive care unit may not be benign. Crit Care Med. 2005 Jun;33(6):1420-1. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15942365" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15942365">PMID 15942365</a>.</li>
<li><a href="http://www.lww.com/product/?0-683-05565-8" class="external text" title="http://www.lww.com/product/?0-683-05565-8" rel="nofollow">The ICU Book by Marino</a></li>
</ul>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.aafp.org/afp/20020501/1823.html" class="external text" title="http://www.aafp.org/afp/20020501/1823.html" rel="nofollow">Acute Respiratory Distress Syndrome - May 1, 2002 - American Family Physician</a></li>
<li><a href="http://rad.usuhs.mil/rad/chest_review/index.html" class="external text" title="http://rad.usuhs.mil/rad/chest_review/index.html" rel="nofollow">Basic Chest X-Ray Review</a></li>
<li><a href="http://www.radiology.vcu.edu/2004%2004%2016%20cotw.htm" class="external text" title="http://www.radiology.vcu.edu/2004%2004%2016%20cotw.htm" rel="nofollow">Transfusion related acute lung injury (TRALI)</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10193545&amp;query_hl=62&amp;itool=pubmed_docsum" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10193545&amp;query_hl=62&amp;itool=pubmed_docsum" rel="nofollow">Antioxidant status in patients with acute respiratory distress syndrome.</a></li>
<li><a href="http://www.ardsnet.org/" class="external text" title="http://www.ardsnet.org/" rel="nofollow">ARDSNet</a> — the NIH / NHLBI ARDS Network</li>
</ul>
<div class="NavFrame" style="clear:both;">
<div class="NavHead">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap; position:absolute; width:auto; left:0.5em;"><a href="../../../r/e/s/Template%7ERespiratory_pathology_aa1c.html" title="Template:Respiratory pathology"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<span style="color: #002bb8;" title="Discussion about this template">d</span>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../r/e/s/Template%7ERespiratory_pathology_aa1c.html" class="external text" title="http://en.wikipedia.org../../../r/e/s/Template%7ERespiratory_pathology_aa1c.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
<b><a href="../../../p/a/t/Pathology.html" title="Pathology">Pathology</a> of <a href="../../../r/e/s/Respiratory_system.html" title="Respiratory system">respiratory system</a> (<a href="../../../d/i/s/ICD-10_Chapter_X%7E_Diseases_of_the_respiratory_system_953b.html" title="ICD-10 Chapter X: Diseases of the respiratory system">J</a>)</b></div>
<div class="NavContent" style="margin:0.5em; font-size:0.9em;">
<p><span style="white-space:nowrap"><strong class="selflink">Acute respiratory distress syndrome</strong> •</span> <span style="white-space:nowrap"><a href="../../../a/d/e/Adenoid_hypertrophy.html" title="Adenoid hypertrophy">Adenoid hypertrophy</a> •</span> <a href="../../../a/s/t/Asthma.html" title="Asthma">Asthma</a>&#160;• <a href="../../../a/t/e/Atelectasis.html" title="Atelectasis">Atelectasis</a>&#160;• <span style="white-space:nowrap"><a href="../../../a/t/r/Atrophic_rhinitis.html" title="Atrophic rhinitis">Atrophic rhinitis</a> •</span> <span style="white-space:nowrap"><a href="../../../b/a/u/Bauxite_fibrosis.html" title="Bauxite fibrosis">Bauxite fibrosis</a> •</span> <a href="../../../b/e/r/Berylliosis.html" title="Berylliosis">Berylliosis</a>&#160;• <a href="../../../b/r/o/Bronchiectasis.html" title="Bronchiectasis">Bronchiectasis</a>&#160;• <a href="../../../b/r/o/Bronchiolitis.html" title="Bronchiolitis">Bronchiolitis</a>&#160;• <a href="../../../b/r/o/Bronchitis.html" title="Bronchitis">Bronchitis</a>&#160;• <a href="../../../b/y/s/Byssinosis.html" title="Byssinosis">Byssinosis</a>&#160;• <span style="white-space:nowrap"><a href="../../../c/o/a/Coalworker%27s_pneumoconiosis.html" title="Coalworker's pneumoconiosis">Coalworker's pneumoconiosis</a> •</span> <span style="white-space:nowrap"><a href="../../../c/o/m/Common_cold.html" title="Common cold">Common cold</a> •</span> <a href="../../../c/o/p/COPD_b576.html" title="COPD">COPD</a>&#160;• <a href="../../../c/r/o/Croup.html" title="Croup">Croup</a>&#160;• <a href="../../../e/m/p/Emphysema.html" title="Emphysema">Emphysema</a>&#160;• <a href="../../../e/m/p/Empyema.html" title="Empyema">Empyema</a>&#160;• <a href="../../../e/p/i/Epiglottitis.html" title="Epiglottitis">Epiglottitis</a>&#160;• <span style="white-space:nowrap"><a href="../../../h/a/m/Hamman-Rich_syndrome_fc9a.html" title="Hamman-Rich syndrome">Hamman-Rich syndrome</a> •</span> <span style="white-space:nowrap"><a href="../../../h/a/y/Hay_fever.html" title="Hay fever">Hay fever</a> •</span> <span style="white-space:nowrap"><a href="../../../h/y/p/Hypersensitivity_pneumonitis.html" title="Hypersensitivity pneumonitis">Hypersensitivity pneumonitis</a> •</span> <a href="../../../i/n/f/Influenza.html" title="Influenza">Influenza</a>&#160;• <span style="white-space:nowrap"><a href="../../../i/n/t/Interstitial_lung_disease.html" title="Interstitial lung disease">Interstitial lung disease</a> •</span> <a href="../../../l/a/r/Laryngitis.html" title="Laryngitis">Laryngitis</a>&#160;• <a href="../../../l/a/r/Laryngospasm.html" title="Laryngospasm">Laryngospasm</a>&#160;• <span style="white-space:nowrap"><a href="../../../l/u/n/Lung_abscess.html" title="Lung abscess">Lung abscess</a> •</span> <a href="../../../m/e/d/Mediastinitis.html" title="Mediastinitis">Mediastinitis</a>&#160;• <span style="white-space:nowrap"><a href="../../../n/a/s/Nasal_polyp.html" title="Nasal polyp">Nasal polyp</a> •</span> <span style="white-space:nowrap"><a href="../../../p/e/r/Peritonsillar_abscess.html" title="Peritonsillar abscess">Peritonsillar abscess</a> •</span> <a href="../../../p/h/a/Pharyngitis.html" title="Pharyngitis">Pharyngitis</a>&#160;• <span style="white-space:nowrap"><a href="../../../p/l/e/Pleural_effusion.html" title="Pleural effusion">Pleural effusion</a> •</span> <a href="../../../p/n/e/Pneumoconiosis.html" title="Pneumoconiosis">Pneumoconiosis</a>&#160;• <a href="../../../p/n/e/Pneumonia.html" title="Pneumonia">Pneumonia</a> <small>(<a href="../../../v/i/r/Viral_pneumonia.html" title="Viral pneumonia">Viral</a>, <a href="../../../b/a/c/Bacterial_pneumonia.html" title="Bacterial pneumonia">Bacterial</a>, <a href="../../../b/r/o/Bronchopneumonia.html" title="Bronchopneumonia">Bronchopneumonia</a>)</small>&#160;• <a href="../../../p/n/e/Pneumothorax.html" title="Pneumothorax">Pneumothorax</a>&#160;• <span style="white-space:nowrap"><a href="../../../p/u/l/Pulmonary_edema.html" title="Pulmonary edema">Pulmonary edema</a> •</span> <span style="white-space:nowrap"><a href="../../../r/e/s/Respiratory_failure.html" title="Respiratory failure">Respiratory failure</a> •</span> <a href="../../../r/h/i/Rhinitis.html" title="Rhinitis">Rhinitis</a>&#160;• <a href="../../../s/i/d/Siderosis.html" title="Siderosis">Siderosis</a>&#160;• <a href="../../../s/i/l/Silicosis.html" title="Silicosis">Silicosis</a>&#160;• <a href="../../../s/i/n/Sinusitis.html" title="Sinusitis">Sinusitis</a>&#160;• <span style="white-space:nowrap"><a href="../../../s/t/a/Status_asthmaticus.html" title="Status asthmaticus">Status asthmaticus</a> •</span> <a href="../../../t/o/n/Tonsillitis.html" title="Tonsillitis">Tonsillitis</a>&#160;• <a href="../../../t/r/a/Tracheitis.html" title="Tracheitis">Tracheitis</a>&#160;• <span style="white-space:nowrap"><a href="../../../u/p/p/Upper_respiratory_tract_infection.html" title="Upper respiratory tract infection">Upper respiratory tract infection</a> •</span> <span style="white-space:nowrap"><a href="../../../v/a/s/Vasomotor_rhinitis.html" title="Vasomotor rhinitis">Vasomotor rhinitis</a> •</span> <span style="white-space:nowrap"><a href="../../../v/o/c/Vocal_fold_nodule.html" title="Vocal fold nodule">Vocal fold nodule</a></span></p>
</div>
</div>

<!-- 
Pre-expand include size: 52146 bytes
Post-expand include size: 26904 bytes
Template argument size: 15938 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/c/u/Acute_respiratory_distress_syndrome.html">http://en.wikipedia.org../../../a/c/u/Acute_respiratory_distress_syndrome.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../c/a/u/Category%7ECauses_of_death_8353.html" title="Category:Causes of death">Causes of death</a></span> | <span dir='ltr'><a href="../../../i/n/t/Category%7EIntensive_care_medicine_d0e6.html" title="Category:Intensive care medicine">Intensive care medicine</a></span> | <span dir='ltr'><a href="../../../p/u/l/Category%7EPulmonology_90c9.html" title="Category:Pulmonology">Pulmonology</a></span> | <span dir='ltr'><a href="../../../s/y/n/Category%7ESyndromes_0e61.html" title="Category:Syndromes">Syndromes</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/c/u/Acute_respiratory_distress_syndrome.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../a/c/u/Talk%7EAcute_respiratory_distress_syndrome_0f03.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Acute_respiratory_distress_syndrome">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../de/a/c/u/Acute_Respiratory_Distress_Syndrome_11d6.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../es/s/%C3%AD/n/S%C3%ADndrome_de_distr%C3%A9s_respiratorio_agudo.html">Español</a>
	      </li>
	      	      <li>
	      <a href="../../../../fr/s/y/n/Syndrome_de_d%C3%A9tresse_respiratoire_aigu%C3%AB.html">Français</a>
	      </li>
	      	      <li>
	      <a href="../../../../nl/a/r/d/ARDS_b20d.html">Nederlands</a>
	      </li>
	      	      <li>
	      <a href="../../../../fi/%C3%A4/k/i/%C3%84killinen_hengitysvaikeusoireyhtym%C3%A4.html">Suomi</a>
	      </li>
	      	      <li>
	      <a href="../../../../sv/a/d/u/Adult_respiratory_distress_syndrome.html">Svenska</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 15:20, 6 April 2007 by Anonymous user(s) of Wikipedia. Based on work by Wikipedia user(s) <a href="../../../m/a/r/User%7EMarcoTolo_8040.html" title="User:MarcoTolo">MarcoTolo</a>, Jongdg, <a href="../../../h/e/h/User%7EHehkuviini_1b20.html" title="User:Hehkuviini">Hehkuviini</a>, V3development, <a href="../../../r/e/n/User%7ERenice_8358.html" title="User:Renice">Renice</a>, <a href="../../../a/r/c/User%7EArcadian_5c4b.html" title="User:Arcadian">Arcadian</a>, Phlegmfighter, <a href="../../../s/m/a/User%7ESmackBot_cc7a.html" title="User:SmackBot">SmackBot</a>, <a href="../../../f/l/y/User%7EFlyHigh_680e.html" title="User:FlyHigh">FlyHigh</a>, <a href="../../../s/u/p/User%7ESuperAntMD_b866.html" title="User:SuperAntMD">SuperAntMD</a>, <a href="../../../a/n/t/User%7EAntandrus_5ef3.html" title="User:Antandrus">Antandrus</a>, <a href="../../../t/h/b/User%7ETHB_9e7b.html" title="User:THB">THB</a>, <a href="../../../j/v/i/User%7EJVinocur_2f40.html" title="User:JVinocur">JVinocur</a>, <a href="../../../d/a/v/User%7EDavidruben_76a6.html" title="User:Davidruben">Davidruben</a>, <a href="../../../b/l/u/User%7EBluebot_e595.html" title="User:Bluebot">Bluebot</a>, Kenneth Gilpin, <a href="../../../s/c/o/User%7EScope_creep_3ef9.html" title="User:Scope creep">Scope creep</a>, <a href="../../../n/e/s/User%7ENescio_e53e.html" title="User:Nescio">Nescio</a>, <a href="../../../t/h/i/User%7EThijs%21bot_bdf4.html" title="User:Thijs!bot">Thijs!bot</a>, <a href="../../../n/e/p/User%7ENephron_555e.html" title="User:Nephron">Nephron</a>, <a href="../../../h/a/i/User%7EHairy_Dude_fc1c.html" title="User:Hairy Dude">Hairy Dude</a>, <a href="../../../m/e/e/User%7EMeersan_8891.html" title="User:Meersan">Meersan</a>, <a href="../../../w/e/l/User%7EWelsh_c865.html" title="User:Welsh">Welsh</a>, <a href="../../../c/h/a/User%7ECharles_Matthews_cceb.html" title="User:Charles Matthews">Charles Matthews</a>, <a href="../../../d/a/3/User%7EDA3N_6a2a.html" title="User:DA3N">DA3N</a>, <a href="../../../d/o/c/User%7EDocJohnny_db09.html" title="User:DocJohnny">DocJohnny</a>, <a href="../../../s/k/a/User%7ESkagedal_c3c6.html" title="User:Skagedal">Skagedal</a>, <a href="../../../v/o/l/User%7EVolfy_6112.html" title="User:Volfy">Volfy</a>, <a href="../../../j/l/a/User%7EJLaTondre_be65.html" title="User:JLaTondre">JLaTondre</a>, <a href="../../../u/n/y/User%7EUnyoyega_ed0f.html" title="User:Unyoyega">Unyoyega</a>, <a href="../../../b/a/b/User%7EBabajobu_ed0d.html" title="User:Babajobu">Babajobu</a>, <a href="../../../g/e/n/User%7EGene_Nygaard_634f.html" title="User:Gene Nygaard">Gene Nygaard</a>, A314268, <a href="../../../e/e/q/User%7EEequor_b13d.html" title="User:Eequor">Eequor</a>, <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a>, <a href="../../../a/l/i/User%7EAlison_304c.html" title="User:Alison">Alison</a>, <a href="../../../c/m/d/User%7ECmdrjameson_3c06.html" title="User:Cmdrjameson">Cmdrjameson</a>, <a href="../../../a/x/l/User%7EAxl_2118.html" title="User:Axl">Axl</a>, <a href="../../../s/i/m/User%7ESimonP_1010.html" title="User:SimonP">SimonP</a>, <a href="../../../r/e/d/User%7ERedWolf_0f32.html" title="User:RedWolf">RedWolf</a>, <a href="../../../e/r/i/User%7EErich_gasboy_b37c.html" title="User:Erich gasboy">Erich gasboy</a>, <a href="../../../d/i/b/User%7EDiberri_3d04.html" title="User:Diberri">Diberri</a>, <a href="../../../t/h/u/User%7EThue_a090.html" title="User:Thue">Thue</a>, <a href="../../../a/s/i/User%7EAside_1d07.html" title="User:Aside">Aside</a>, <a href="../../../a/l/t/User%7EAlteripse_f1cb.html" title="User:Alteripse">Alteripse</a>, <a href="../../../m/i/c/User%7EMichael_Rowe_75f0.html" title="User:Michael Rowe">Michael Rowe</a> and <a href="../../../b/e/n/User%7EBensaccount_5cd4.html" title="User:Bensaccount">Bensaccount</a>.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
